|
Quotes & Info
|
| HGRD > SEC Filings for HGRD > Form 10-K on 16-Mar-2009 | All Recent SEC Filings |
16-Mar-2009
Annual Report
REVENUE AND EXPENSE COMPONENTS
The following descriptions of the components of revenues and expenses apply to
the comparison of results of operations.
Ratings and advisory revenue. We currently operate in one business segment. We
provide proprietary, objective healthcare provider ratings and advisory services
to our clients. We generate revenue by providing our clients with information
and other assistance that enable them to measure, assess, enhance and market
healthcare quality. Our target clients include hospitals, employers, benefits
consulting firms, payers, insurance companies and consumers. We typically
receive a non-refundable payment at the beginning of each year of the contract
term (which is typically three years, subject to a cancellation right by either
the client or us, on each annual anniversary date, with certain exceptions). We
record the cash payment as deferred revenue that is then amortized to revenue on
a straight-line basis over the respective year of the term. Certain of our
products represent a one-time delivery of data. For these arrangements, we
recognize revenue at the time that the data is delivered.
Cost of ratings and advisory revenue. Cost of ratings and advisory revenue
consists primarily of the costs associated with the delivery of services related
to our SQI, SQP and QAI programs, as well as the costs incurred to acquire the
data utilized in connection with these and other services such as our Health
Management Suite of products. The cost of delivery of services relates primarily
to the client consultants and support staff that provide our services.
Sales and marketing costs. Sales and marketing costs include salaries, wages and
commission expenses related to our sales efforts, as well as other direct sales
and marketing costs. For our SQP, SQI and QAI agreements, we pay our sales
personnel commissions as we receive payment from our hospital clients. In
addition, we record the commission expense in the period it is earned, which is
typically upon contract execution for the first year of the agreement and on
each anniversary date for clients that do not cancel in the second or third year
of the contract term. We record the commission expense in this manner because
once a contract is signed, the salesperson has no remaining obligations to
perform during the agreement in order to earn the commission.
Product development costs. We incur product development costs related to the
development and support of our website and the development of applications to
support data compilation and extraction for our consulting services. These costs
are expensed as incurred unless the criteria for capitalization under American
Institute of Certified Public Accountants Statement of Position 98-1, Accounting
for the Costs of Computer Software Developed or Obtained for Internal Use ("SOP
98-1") are met.
General and administrative expenses. General and administrative expenses consist
primarily of salaries, employee benefits and other expenses for employees that
support our infrastructure such as finance and accounting personnel, certain
information technology employees and some of our support staff, facility costs,
legal, accounting and other professional fees and insurance costs.
RESULTS OF OPERATIONS
Ratings and Advisory Revenue Overview
Year ended Year ended Year ended
Product Area December 31, 2008 December 31, 2007 December 31, 2006
Provider Services $ 29,261,442 $ 25,130,997 $ 20,068,557
Internet Business Group 8,392,948 6,132,250 5,099,838
Strategic Health Solutions 2,008,994 1,478,363 2,595,626
Total $ 39,663,384 $ 32,741,610 $ 27,764,021
|
YEAR ENDED DECEMBER 31, 2008 COMPARED TO YEAR ENDED DECEMBER 31, 2007
Ratings and advisory revenue. Total ratings and advisory revenue for the year
ended December 31, 2008 increased 21% to approximately $39.7 million from
$32.7 million for the year ended December 31, 2007 as a result of strong growth
from Provider Services and Internet Business Group. Sales of our suite of
marketing and quality assessment and improvement products to hospitals were the
principal reason for this increase. For the years ended December 31, 2008 and
2007, approximately 62% and 66%, respectively, of our ratings and advisory
revenue was derived from our marketing services to hospitals. Revenues from our
marketing services to hospitals increased by approximately $3.1 million to
$24.6 million for the year ended December 31, 2008. This increase is principally
due to the addition of new clients, as well as our continued success selling
additional services to existing hospitals. For 2008, sales of additional
services to existing hospitals accounted for nearly 34% of total new contracted
sales. Approximately 21% and 19% of our ratings and advisory revenue was derived
from sales of our quality reports to consumers, Connecting Point program and
website advertising and sponsorship revenue for the years ended December 31,
2008 and 2007, respectively. Approximately 11% and 10% of our ratings and
advisory revenue was derived from the sale of our quality improvement services
to hospitals for the years ended December 31, 2008 and 2007, respectively.
Finally, sales of our quality information to employers, benefits consulting
firms, and health plans accounted for approximately 5% of our ratings and
advisory revenue for 2008 and 2007.
Provider Services. For the year ended December 31, 2008, Provider Services
revenue, which principally includes sales of hospital marketing products and
quality improvement products, was approximately $29.3 million, an increase of
$4.1 million, or 16% over the year ended December 31, 2007. This increase
principally reflects sales of our marketing products to new hospital clients and
increased sales to existing clients. For 2008, nearly 34% of all our new sales
in our Provider Services area were to existing clients. For the years ended
December 31, 2008 and 2007, we retained, or signed new contracts representing
approximately 80% and 70%, respectively, of the annual contract value of
hospitals whose contracts had first or second year anniversary dates.
Internet Business Group. For the year ended December 31, 2008, Internet Business
Group revenue, which includes the sale of our quality reports to consumers,
revenue from our Connecting Point program (formerly, Internet Patient
Acquisition) and website advertising and sponsorship revenue, was approximately
$8.4 million, an increase of $2.3 million, or 37% over the year ended
December 31, 2007. This increase in revenue was principally due to our
Connecting Point agreement with Fresenius Medical Care North America signed in
June 2008. The Company's internet and sponsorship revenue increased in part due
to the acquisition of certain operating assets of Adviware in October 2008. Also
contributing to the increase in internet and sponsorship revenue was a full year
of advertising revenue on www.healthgrades.com, as compared to revenues only in
the second half of 2007. These increases were partially offset by a slight
decrease in sales of quality reports to consumers.
Strategic Health Solutions. For the year ended December 31, 2008, Strategic
Health Solutions revenue, which includes sales of our quality information to
employers, benefit consultants, health plans and others and sales of our data,
was approximately $2.0 million, an increase of $0.5 million, or 36% over the
year ended December 31, 2007.
Cost of ratings and advisory revenue. For the years ended December 31, 2008 and
2007, cost of ratings and advisory revenue was approximately $6.8 million and
$5.3 million, respectively, or approximately 17% and 16% of ratings and advisory
revenue. The increase in cost of ratings and advisory revenue as a percentage of
ratings and advisory revenue was due in part to an increase in the number of
employees providing support services to our Provider Services products.
Other Revenue. Other revenue for the year ended December 31, 2007 primarily
represents approximately $3.4 million of the $4.5 million total award granted to
us by the panel of arbitrators with respect to our claims against Hewitt
regarding an agreement between us and Hewitt that was entered into in July 2005.
The panel's award was based upon the three-year minimum annual revenue guarantee
to us under the Hewitt agreement. This guarantee was $3.0 million annually for
2007, 2008 and 2009. The panel reduced this amount by its estimate of expected
costs of generating these revenues. After deriving a net revenue amount, the
panel performed a present value calculation of the net revenue amount utilizing
a discount rate of 15%.
Sales and marketing costs. Sales and marketing costs for the year ended
December 31, 2008 increased to approximately $10.8 million from $9.1 million for
the year ended December 31, 2007. As a percentage of sales, sales and marketing
costs increased to 27% for the year ended December 31, 2008, compared to 25% for
the year ended December 31, 2007. The increase in sales and marketing for the
year ended December 31, 2008 is primarily due to the increase in commission
expenses, which are recorded upon contract execution. In addition, sales and
marketing costs increased to promote internet advertising, an advertising
platform that we launched in the second half of 2007.
Product development costs. Product development costs for the year ended
December 31, 2008 increased to approximately $7.3 million from $5.5 million for
the year ended December 31, 2007. This increase is principally due to additional
personnel hired to support our product development efforts, including both the
improvement of existing products as well as the development of new product
offerings. In particular, we added personnel to focus on advertising
initiatives, as well as several projects that are in process with our search
engine partners. In addition, we continue to invest in the improvement of our
physician data. The physician data we maintain relates to over 750,000
physicians. This data does not identify physicians by a unique physician
identifier (such as a social security number for an individual). Therefore, in
order to properly match the various data points that we maintain to the
appropriate physician, we must conduct a robust matching process. We continue to
acquire new physician data and refine our matching process to improve the
accuracy of our data.
General and administrative expenses. For the year ended December 31, 2008,
general and administrative expenses were approximately $8.1 million, an increase
of approximately $1.1 million from general and administrative expenses of
approximately $7.0 million for the year ended December 31, 2007. Included as a
reduction in general and administrative expenses for the year ended December 31,
2007 is approximately $0.9 million in legal fees awarded to us by the panel of
arbitrators in the Hewitt arbitration that was recorded as a reduction to
expenses.
Interest expense. For the year ended December 31, 2008, we incurred interest
expense of approximately $2,700 with respect to interest paid on capital lease
obligations for the security system lease at our facility in Golden and other
items.
Interest income. We maintain cash in an overnight investment account that
includes short-term U.S. government obligations with maturities not exceeding
three months and investments in a short-term investment account that includes
U.S. government and government agency debt securities with original maturities
not exceeding three months. As of December 31, 2008, our total investment in
these accounts totaled to approximately $9.8 million. This amount is included
within the cash and cash equivalents line item of our balance sheet. For the
year ended December 31, 2008, interest earned on this account was approximately
$0.4 million. Interest income in 2008 decreased by approximately $0.9 million or
68% from the year ended December 31, 2007 principally due to lower cash balances
and lower investment yields resulting from a decrease in market interest rates
earned on invested cash. Also included in interest income for the year ended
December 31, 2007 is approximately $0.2 million from the Hewitt arbitration
award. Any further decrease in interest rates in either of these investment
accounts would not have a material impact on our financial position.
YEAR ENDED DECEMBER 31, 2007 COMPARED TO YEAR ENDED DECEMBER 31, 2006
Ratings and advisory revenue. Total ratings and advisory revenue for the year
ended December 31, 2007 increased 18% to approximately $32.7 million from
$27.8 million for the year ended December 31, 2006 as a result of strong growth
from Provider Services. Sales of our suite of marketing and quality assessment
and improvement products to hospitals were the principal reason for this
increase. For the year ended December 31, 2007 and 2006, approximately 66% and
61%, respectively, of our ratings and advisory revenue was derived from our
marketing services to hospitals. Revenues from our marketing services to
hospitals increased by approximately $4.5 million to $21.5 million for the year
ended December 31, 2007. This increase is principally due to the addition of new
clients, as well as our continued success selling additional services to
existing hospitals. For 2007, sales of additional services to existing hospitals
accounted for nearly 24% of total new contracted sales. Approximately 18% of our
ratings and advisory revenue was derived from sales of our quality reports to
consumers and our Connection Point program for the years ended December 31, 2007
and 2006. Approximately 10% of our ratings and advisory revenue was derived from
the sale of our quality improvement services to hospitals for the years ended
December 31, 2007 and 2006. Finally, sales of our quality information to
employers, benefits consulting firms, and health plans accounted for
approximately 5% of our ratings and advisory revenue for 2007 compared to 9% for
the same period of 2006.
Provider Services. For the year ended December 31, 2007, Provider Services
revenue was approximately $25.1 million, an increase of $5.1 million, or 25%
over the year ended December 31, 2006. This increase principally reflects sales
of our marketing products to new hospital clients and increased sales to
existing clients. For 2007, nearly 24% of all our new sales in our Provider
Services area were to existing hospitals. For the years ended December 31, 2007
and 2006, we retained, or signed new contracts representing approximately 70%
and 75%, respectively, of the annual contract value of hospitals whose contracts
had first or second year anniversary dates.
Internet Business Group. For the year ended December 31, 2007, Internet Business
Group revenue was approximately $6.1 million, an increase of $1.0 million, or
20% over the year ended December 31, 2006. This increase was due to an increase
in revenue our Connecting Point product, which is primarily a result of our
agreement with Tenet HealthSystem signed in the second quarter of 2006. In
addition, the fourth quarter of 2007 includes some revenue from advertising
while the fourth quarter of 2006 included no advertising revenue. These
increases were partially offset by a slight decrease in sales of quality reports
to consumers as we continued to make information free to them.
In 2007, the majority of our advertising revenue came from advertisements placed
through the Google AdSense platform. During the second half of 2007, we began to
place advertisements on our website and signed our first test advertising
campaign with a pharmaceutical company. In addition, we implemented DoubleClick
as our ad serving engine at the end of December 2007.
Strategic Health Solutions. For the year ended December 31, 2007, Strategic
Health Solutions revenue was approximately $1.5 million, a decrease of
$1.1 million, or 43% from the year ended December 31, 2006. Contributing to this
decrease is the fact that the sales cycle for the sales of our quality
information to employers, benefit consultants, health plans and others is very
lengthy. In some cases, the time from initial contact to sales close can be as
much as a year or more.
Cost of ratings and advisory revenue. For the years ended December 31, 2007 and
2006, cost of ratings and advisory revenue was approximately $5.3 million and
$4.6 million, respectively, or approximately 16% and 17% of ratings and advisory
revenue. The decrease in cost of ratings and advisory revenue as a percentage of
ratings and advisory revenue was due in part to the slight decrease in our cost
to acquire data. In addition, sales consultant costs remained relatively
consistent while ratings and advisory revenue increased.
Other Revenue. Other revenue for the year ended December 31, 2007 primarily
represents approximately $3.4 million of the $4.5 million total award granted to
us by the panel of arbitrators with respect to our claims against Hewitt.
Sales and marketing costs. Sales and marketing costs for the year ended
December 31, 2007 increased to approximately $9.1 million from $8.4 million for
the year ended December 31, 2006. As a percentage of ratings and advisory
revenue, sales and marketing costs were 28% and 30%, in 2007 and 2006,
respectively. Sales and marketing costs were lower for the year ended
December 31, 2007 compared to 2006, as a percentage of ratings and advisory
revenue, mainly as a result of greater focusing our investments in product
development costs.
Product development costs. Product development costs for the year ended
December 31, 2007 increased to approximately $5.5 million from $3.5 million for
the year ended December 31, 2006. This increase is principally due to additional
personnel hired to support our product development efforts, including both the
improvement of existing products as well as the development of new product
offerings. In particular, we added personnel to focus on advertising
initiatives, as well as several projects that are in process with our search
engine partners. In addition, we continue to invest in the improvement of our
physician data.
General and administrative expenses. For the year ended December 31, 2007,
general and administrative expenses were approximately $7.0 million, an increase
of approximately $0.6 million from general and administrative expenses of
approximately $6.4 million for the year ended December 31, 2006. Included as a
reduction in general and administrative expenses for the year ended December 31,
2007 is approximately $0.9 million in legal fees awarded to us by the panel of
arbitrators in the Hewitt arbitration that was recorded as a reduction to
expenses, offset by a net increase of approximately $1.5 million resulting
primarily from increases in personnel costs.
Interest expense. For the year ended December 31, 2007, we incurred interest
expense of approximately $1,800 with respect to interest paid on capital lease
obligations for the security system lease at our facility in Golden and other
items.
Interest income. We maintain cash in an overnight investment account that
includes short-term U.S. government obligations with maturities not exceeding
three months and investments in a short-term investment account that includes
U.S. government and government agency debt securities with original maturities
not exceeding three months. As of December 31, 2007, our total investment in
these accounts totaled to approximately $22.5 million. This amount is included
within the cash and cash equivalents line item of our balance sheet. For the
year ended December 31, 2007, interest earned on this account was approximately
$1.1 million. Also included in interest income is approximately $0.2 million
from the Hewitt arbitration award. Interest income in 2007 compared to 2006
increased by approximately $0.6 million or 93% principally because cash flows
increased significantly year over year.
LIQUIDITY AND CAPITAL RESOURCES
As of December 31, 2008, we had $11.3 million in cash and cash equivalents, a
52% decrease from the balance at December 31, 2007. The decrease is due to the
acquisition of certain operating assets of Adviware for $6.7 million and stock
repurchases of $10.7 million, offset by $6.4 million in cash flow from
operations for the year ended December 31, 2008.
As of December 31, 2008, we had a working capital deficit of approximately
$2.1 million, a decrease of $12.3 million from working capital of approximately
$10.2 million as of December 31, 2007. Included in current liabilities as of
December 31, 2008 is $19.7 million in deferred revenue, which principally
represents contract payments for future marketing and quality improvement
services to hospitals. These amounts will be reflected in revenue upon provision
of the related services.
For the year ended December 31, 2008, cash provided by operations was approximately $6.4 million compared to cash provided by operations of approximately $12.3 million for the year ended December 31, 2007, a decrease of approximately $5.9 million, primarily due to the 2007 collection of $4.5 million from Hewitt. For the year ended December 31, 2008, we paid approximately $2.4 million in estimated income tax payments. Net cash flow used in investing activities was approximately $8.5 million for the year ended December 31, 2008, compared to approximately $0.8 million for the year ended December 31, 2007, an increase of cash used of approximately $7.8 million. During the years ended December 31, 2008 and 2007, we incurred approximately $1.9 million and . . .
|
|